Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2012 06:50 ET | Source: VIVUS, Inc.

VIVUS Announces Qsymia(TM) Scientific Presentations at the 48th Annual EASD Meeting

MOUNTAIN VIEW, Calif., Oct. 3, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced several Qsymia scientific presentations at the 48th Annual Meeting of European Association for the...
October 02, 2012 07:00 ET | Source: VIVUS, Inc.

Vivus Announces 2012 Medical Societal Meeting Schedule for Qsymia (Phentermine and Topiramate Extended-Release) CIV

MOUNTAIN VIEW, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the Qsymia™ medical societal meeting schedule upcoming in 2012. The VIVUS presence and Qsymia...
September 21, 2012 07:00 ET | Source: VIVUS, Inc.

VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application

MOUNTAIN VIEW, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that based on preliminary feedback from the European Medicines Agency's (EMA) Committee for...
September 04, 2012 06:45 ET | Source: VIVUS, Inc.

VIVUS to Present at Six Investor Conferences in September

MOUNTAIN VIEW, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Timothy Morris, Chief Financial Officer, and Barbara Troupin, Vice President of Scientific...
August 07, 2012 16:00 ET | Source: VIVUS, Inc.

VIVUS Reports Second Quarter and First Six Months 2012 Financial Results

MOUNTAIN VIEW, Calif., Aug. 7, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...
August 01, 2012 06:45 ET | Source: VIVUS, Inc.

VIVUS Announces Date of Analyst Event and Second Quarter 2012 Financial Results Conference Call

MOUNTAIN VIEW, Calif., Aug. 1, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will host an analyst event to discuss commercial plans for Qsymia™ and to report...
June 13, 2012 06:45 ET | Source: VIVUS, Inc.

VIVUS to Present at the 2012 Wells Fargo Securities Healthcare Conference

MOUNTAIN VIEW, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the 2012...
June 05, 2012 06:45 ET | Source: VIVUS, Inc.

VIVUS Provides Update on Timing of European Decision for Qnexa(R)

MOUNTAIN VIEW, Calif., June 5, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
May 07, 2012 16:00 ET | Source: VIVUS, Inc.

VIVUS Reports First Quarter 2012 Financial Results

MOUNTAIN VIEW, Calif., May 7, 2012 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...
May 04, 2012 06:45 ET | Source: VIVUS, Inc.

VIVUS to Present at Three Investor Conferences in May

MOUNTAIN VIEW, Calif., May 4, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at three investor...